Varkevisser M - Search Results

1

Price effects of a hospital merger: Heterogeneity across health insurers, hospital products, and hospital locations.

Roos AF, Croes RR, Shestalova V, Varkevisser M, Schut FT. Roos AF, et al. Among authors: varkevisser m. Health Econ. 2019 Sep;28(9):1130-1145. doi: 10.1002/hec.3920. Epub 2019 Jul 1. Health Econ. 2019. PMID: 31264329 Free PMC article.

2

Why do patients bypass the nearest hospital? An empirical analysis for orthopaedic care and neurosurgery in the Netherlands.

Varkevisser M, van der Geest SA. Varkevisser M, et al. Eur J Health Econ. 2007 Sep;8(3):287-95. doi: 10.1007/s10198-006-0035-0. Epub 2007 Jan 26. Eur J Health Econ. 2007. PMID: 17256180 Free article.

3

Defining hospital markets for antitrust enforcement: new approaches and their applicability to The Netherlands.

Varkevisser M, Capps CS, Schut FT. Varkevisser M, et al. Health Econ Policy Law. 2008 Jan;3(Pt 1):7-29. doi: 10.1017/S1744133107004331. Health Econ Policy Law. 2008. PMID: 18634630

4

Assessing hospital competition when prices don't matter to patients: the use of time-elasticities.

Varkevisser M, van der Geest SA, Schut FT. Varkevisser M, et al. Int J Health Care Finance Econ. 2010 Mar;10(1):43-60. doi: 10.1007/s10754-009-9070-6. Epub 2009 Aug 7. Int J Health Care Finance Econ. 2010. PMID: 19662527

5

Pharmaceutical policy in the Netherlands: from price regulation towards managed competition.

Boonen LH, van der Geest SA, Schut FT, Varkevisser M. Boonen LH, et al. Among authors: varkevisser m. Adv Health Econ Health Serv Res. 2010;22:53-76. doi: 10.1108/s0731-2199(2010)0000022006. Adv Health Econ Health Serv Res. 2010. PMID: 20575228 Review.

6

The impact of geographic market definition on the stringency of hospital merger control in Germany and the Netherlands.

Varkevisser M, Schut FT. Varkevisser M, et al. Health Econ Policy Law. 2012 Jul;7(3):363-81. doi: 10.1017/S1744133112000011. Epub 2012 Feb 21. Health Econ Policy Law. 2012. PMID: 22348390

7

Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the Netherlands.

Varkevisser M, van der Geest SA, Schut FT. Varkevisser M, et al. J Health Econ. 2012 Mar;31(2):371-8. doi: 10.1016/j.jhealeco.2012.02.001. Epub 2012 Feb 10. J Health Econ. 2012. PMID: 22425770

8

Tackling hospital waiting times: the impact of past and current policies in the Netherlands.

Schut FT, Varkevisser M. Schut FT, et al. Among authors: varkevisser m. Health Policy. 2013 Nov;113(1-2):127-33. doi: 10.1016/j.healthpol.2013.05.003. Epub 2013 Jun 6. Health Policy. 2013. PMID: 23746931

9

Using the deductible for patient channeling: did preferred providers gain patient volume?

van der Geest SA, Varkevisser M. van der Geest SA, et al. Among authors: varkevisser m. Eur J Health Econ. 2016 Jun;17(5):645-52. doi: 10.1007/s10198-015-0711-z. Epub 2015 Aug 1. Eur J Health Econ. 2016. PMID: 26231983 Free PMC article.

10

Competition among health care providers: helpful or harmful?

Barros PP, Brouwer WB, Thomson S, Varkevisser M. Barros PP, et al. Among authors: varkevisser m. Eur J Health Econ. 2016 Apr;17(3):229-33. doi: 10.1007/s10198-015-0736-3. Eur J Health Econ. 2016. PMID: 26467166 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters